Abrupt discontinuation deprescribing vs continued use
Lack of symptom control · people with mild to moderate esophagitis, symptomatic, aged > 18 years (mean age 73 years)
It is very uncertain whether abrupt discontinuation deprescribing changes lack of symptom control compared with continued use (very low certainty).
1 finding from 1 review
- Deprescribing versus continuation of chronic proton pump inhibitor use in adults 2017 · Cochrane Headline outcomes onlyRR 3.02 [1.74, 5.24]1 study · 105 participantsVery low